Cytarabine - CYTARABINE
Navigation: NDC > Supplier starting with: A > APP PHARMACEUTICALS, LLC| Field | Value |
|---|---|
| NDC Code: | 63323-120 |
| Proprietary Name: | Cytarabine |
| Suffix: | |
| Non-Proprietary Name: | CYTARABINE |
| Dosage Form: | INJECTION, SOLUTION |
| Method: | INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS |
| Original Marketing Date: | 29-11-2004 |
| Category Name: | ANDA |
| Application Number: | ANDA076512 |
| Labeler: | APP PHARMACEUTICALS, LLC |
| Substance Name: | CYTARABINE |
| Active Numerator Strength: | 100 |
| Active Ingredient Unit: | mg/mL |
| Pharm Classes: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| DEA Schedule: |